Opinion: Testing-the-waters communications allow companies, founders and sponsors to confidentially assess investor interest ...
The IPO class of 2026 is likely to receive its first incumbent, after Aktis Oncology set its sights on a public listing that could see proceeds of around $210m. The cancer treatment-focused biotech ...
With listings now occurring later in a company’s life cycle, there could be implications for post-IPO share price performance ...
A potential initial public offering (IPO) next year by cryptocurrency exchange Kraken may attract fresh capital from traditional finance (TradFi) investors. Bitcoin recorded an all-time high price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results